Page 22 - Alpine High News Today : Breaking News, Live Updates & Top Stories | Vimarsana
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Apache Corporation of Class Action Lawsuit and Upcoming Deadline
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
CLASS ACTION UPDATE for CLSK, EH and APA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DEADLINE ALERT for EBIX, APA, MPLN, UAVS: Law Offices of Howard G. Smith Reminds Investors of .
Law Offices of Howard G. SmithMarch 17, 2021 GMT
BENSALEM, Pa., March 17, 2021 (GLOBE NEWSWIRE) Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
Moore Kuehn, PLLC Encourages Investors of AQST, REGI or APA to Contact Law Firm
News provided by
Share this article
Share this article
NEW YORK, March 16, 2021 /PRNewswire/ Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:
Aquestive Therapeutics (NASDAQ: AQST)
(1) data included in the Libervant NDA submission showed a lower drug exposure level than desired for certain weight groups; (2) the foregoing significantly decreased the Libervant NDA s approval prospects; and (3) as a result, it was foreseeable that the FDA would not approve the Libervant NDA in its current form.
APA INVESTOR NEWS: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages APA Corporation f/k/a Apache Corporation Investors with Large Losses to Secure Counsel Before Important Deadline – APA
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.